In ET or PMF, mutations can also be found in the gene coding for the thrombopoietin receptor itself (MPL, 5–10%) [5,6,14,15,16], or in the gene coding for the ER resident quality control protein CALR (25–40%) [5,17,18]. Here, MPL is linked to essential thrombocythemia.